Cargando…
Use of amniotic membrane graft in the surgical management of cicatricial ectropion associated with cetuximab therapy
Cetuximab (Erbitux) is an antiepidermal growth factor receptor (EGFR) monoclonal antibody that has been shown to delay the progression of metastatic colorectal cancer. The cutaneous side effects of cetuximab resulting from its effects on normal epidermal cells are well established. Periocular side e...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287927/ https://www.ncbi.nlm.nih.gov/pubmed/25576167 http://dx.doi.org/10.1093/jscr/rju143 |